Targeting Tumor-Induced Immunosuppression Using Conventional Cancer Therapeutics

JSON

Eriksson E, Lövgren T, Loskog A

MRAJ 9 (12) - [2021-00-00; online 2021-00-00]

DOI 10.18103/mra.v9i12.2606

Crossref 10.18103/mra.v9i12.2606